PATENT CLAIM ANALYSIS

Application Number: 16216420
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "318000"]

Abstract:
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

Claim (Index 9):
The compound of  claim 2 , wherein R 1  is methyl; and R 3  and R 4  are hydrogen.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15320810', '15320813', '15320815', '16063059', '15911797']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8340461067000978
- 35 USC 102 Novelty (BERT): 0.5601187114140688
- Combined Prediction Score: 0.8066533671714948
- Mean Citation Score: 389.451514
- Max Citation Score: 427.36118
- Similarity Product: 376.8811692592298

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test